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Abstract
Carney complex (CNC) is an inherited neoplasia syndrome with endocrine overactivity. Its most frequent endocrine
manifestation is primary pigmented nodular adrenocortical disease (PPNAD), a bilateral adrenocortical hyperplasia causing
pituitary-independent Cushing’s syndrome. Inactivating mutations in PRKAR1A, a gene encoding the type 1 a-regulatory
subunit (R1a) of the cAMP–dependent protein kinase (PKA) have been found in 80% of CNC patients with Cushing’s
syndrome. To demonstrate the implication of R1a loss in the initiation and development of PPNAD, we generated mice
lacking Prkar1a specifically in the adrenal cortex (AdKO). AdKO mice develop pituitary-independent Cushing’s syndrome
with increased PKA activity. This leads to autonomous steroidogenic genes expression and deregulated adreno-cortical cells
differentiation, increased proliferation and resistance to apoptosis. Unexpectedly, R1a loss results in improper maintenance
and centrifugal expansion of cortisol-producing fetal adrenocortical cells with concomitant regression of adult cortex. Our
data provide the first in vivo evidence that loss of R1a is sufficient to induce autonomous adrenal hyper-activity and bilateral
hyperplasia, both observed in human PPNAD. Furthermore, this model demonstrates that deregulated PKA activity favors
the emergence of a new cell population potentially arising from the fetal adrenal, giving new insight into the mechanisms
leading to PPNAD.
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Introduction
Primary pigmented nodular adrenocortical disease (PPNAD) is
a rare form of bilateral micronodular adrenocortical hyperplasia
leading to high morbidity due to ACTH (adreno corticotropic
hormone)-independent Cushing’s syndrome. PPNAD may be
either sporadic or regarded as the most frequent endocrine
manifestation of Carney complex (CNC), an autosomal dominant
multiple neoplasia syndrome characterized by cardiac myxomas,
spotty skin pigmentation and endocrine overactivity [1]. Cushing’s
syndrome in PPNAD is most diagnosed in children and young
adults. Both isolated PPNAD and CNC have been associated with
inactivating mutations in PRKAR1A, the gene encoding the type 1a
regulatory subunit (R1a) of the cAMP-dependent protein kinase
(PKA) [2,3]. Among CNC patients with Cushing’s syndrome, the
frequency of PRKAR1A mutations is about 80%. Tumour-specific
loss of heterozygosity within the chromosomal region harboring
PRKAR1A is observed in tumours from CNC patients and isolated
PPNAD, suggesting that PRKAR1A is a potential tumour
suppressor gene [4]. Because general homozygous loss of Prkar1a
is lethal in early mouse embryos, various haploinsufficiency and
tissue-specific knock-out models have been engineered to demon-
strate its tumour suppressor activity [5,6]. General down-
regulation of R1a levels has been achieved either in mouse lines
heterozygous for a null allele of Prkar1a [6,7] or in a transgenic line
carrying an inducible antisense-construct [8]. Both approaches
indicate that haploinsufficiency for Prkar1a predisposes to tumour
formation in a spectrum of endocrine and non-endocrine tissues
that are cAMP-responsive; the mouse phenotype partially overlaps
with the human one. However haploinsufficiency in mouse models
does not appear to be sufficient to promote tumour formation in a
subset of tissues known for their propensity to develop neoplasms
in CNC patients. Thus, complete loss of Prkar1a using heart-,
Schwann cell- or pituitary-specific knockouts was required to
PLoS Genetics | www.plosgenetics.org 1 June 2010 | Volume 6 | Issue 6 | e1000980induce tumours in these tissues [9–11]. To date, although PPNAD
is the most frequent endocrine disorder observed in CNC patients
[12], little is known on its pathophysiology. No clear adrenal
lesions nor Cushing’s syndrome were observed in mouse models of
haploinsufficiency, suggesting that complete loss of Prkar1a might
be required to phenocopy human phenotype. To address directly
this question and obtain a possible mouse model for PPNAD, we
produced mice with targeted Prkar1a gene inactivation in adreno-
cortical cells by mating Prkar1a floxed mice with Akr1b7-Cre mouse
line, a Cre expressing line allowing specific gene ablation in the
steroidogenic lineage of the adrenals [13]. Adrenal cortex-specific
Prkar1a knockout mice (AdKO) develop pituitary-independent
Cushing’s syndrome and evident signs of deregulated adreno-
cortical cells differentiation and hyperplasia. These defects lead to
improper maintenance and expansion of foetal adrenal cells in
adult adrenals and establishment of tumoural conditions. Dereg-
ulation of the inhibin-activin signalling pathway seems to be
implicated in this improper maintenance in AdKO mice model
and in the human pathology. Our data provide the first in vivo
evidence that the absence of R1a subunit of PKA is sufficient to
induce the autonomous adrenal hyper-activity and bilateral
hyperplasia observed in PPNAD. They also strongly suggest that
deregulated PKA activity positively affects the maintenance of
foetal characteristics in adult adrenal glands.
Results
Efficient ablation of Prkar1a in the adrenal cortex of
AdKO mice
To assess the impact of complete loss of Prkar1a on adreno-
cortical function and initiation of PPNAD, we crossed the
Akr1b7:Cre line [13] with mice carrying the conditional null allele
Prkar1a
loxP [6] to produce adrenal cortex-specific KO mice of the
Akr1b7:Cre;Prkar1a
loxP/loxP genotype (Figure 1A). In this study, these
mice were referred to as AdKO mice, and wild-type mice (WT)
were of the Prkar1a
loxP/loxP genotype. The Prkar1a
D2 allele (KO
allele) was detected by PCR in the DNA extracted from AdKO
adrenals but absent from gonads and WT tissues (Figure 1B). As
expected the intact conditional allele was still detected in the
adrenals since Cre-mediated recombination was not supposed to
occur in the whole organ but only in the cortex. Western blot and
RT-QPCR analyses confirmed that Prkar1a gene expression was
impaired in the adrenal glands of AdKO mice at both the mRNA
(50% decrease) and protein levels (60% decrease) (Figure S1A and
Figure 1C) when compared to WT. The 60% loss of R1a protein
in adrenal tissue lysate of AdKO mice was accompanied by a
significant increase in accumulation of R2b and C PKA subunits
(Figure 1C), a phenomenon that is also observed in PPNAD [8].
By contrast, no significant changes were observed at the mRNA
levels, indicating that upregulation of R2b and C subunits,
involved a post-trancriptional mechanism (Figure S1B). We
performed mRNA in situ hybridization and immunostaining to
confirm that the decrease of Prkar1a gene expression was due to
Cre-mediated gene ablation within the cortical compartment. As
shown in Figure 1D, R1a mRNA signal was unaffected in medulla
but was lost in the vast majority of cortical cells. These
observations were confirmed at the protein level by R1a
immunostaining (Figure 1D).
AdKO mice were born at expected Mendelian frequency and
no difference in viability, weight or blood glucose values was
observed up to 18 months of age when compared to WT mice
(data not shown). Adrenal endocrine function and histological
differentiation were explored in groups of mice of both sexes at 5,
10 and 18 months of age.
AdKO mice progressively develop ACTH–independent
Cushing’s syndrome
Visual examination of AdKO females from the age of 10
months onwards revealed neck humps formed of large accumu-
lations of adipose tissue. This ‘‘buffalo hump’’ phenotype was
never observed in WT females (Figure 2A) nor in males of both
genotypes (not shown). Alteration of the repartition of fat depots is
one of the features of ‘‘classic’’ Cushing’s syndrome and is
observed in PPNAD patients with PRKAR1A inactivation. In
agreement with these observations, basal corticosterone levels in
plasma were at least 2-fold higher in 10- and 18-month-old AdKO
females than in age-matched WT, while no difference could be
detected at 5 months (Figure 2B). Basal corticosterone levels were
not affected in AdKO males of 5 months (8.966.3 ng/mL in WT
vs 7.865.0 ng/mL in AdKO), 10 months (8.566.5 ng/mL in WT
vs 7.862.1 ng/mL in AdKO) or 18 months of age (7.064.6 ng/
mL in WT vs 8.264.2 ng/mL in AdKO). ACTH levels were
measured in plasma of 10 months females. Importantly, ACTH
levels measured in AdKO females were at least unchanged or
tended to decrease (2167 pg/mL in WT vs 1467 pg/mL in
AdKO), indicating that their basal hypercorticosteronaemia was
independent of pituitary and likely resulted from primary adrenal
overactivity. To explore the mechanism of hypercorticosteronae-
mia, AdKO mice that had not declared frank Cushing’s syndrome,
i.e. 5 months females and 10 months males, were injected with
dexamethasone to induce a complete blockade of the hypotha-
lomo-pituitary-adrenal (HPA) axis and subsequent suppression of
ACTH production (Figure 2C–2E). Dexamethasone suppression
test led to the expected decrease of adrenal weight (measured in
females) as well as cortical atrophy in WT mice but had no effect
on AdKO adrenals (Figure 2C, 2D and S2). Moreover,
corticosterone levels were undetectable in plasma of WT mice
after dexamethasone treatment whereas they remained unaltered
in AdKO mice (Figure 2E). Finally, ACTH replacement in
dexamethasone-treated mice restored corticosterone levels in WT
Author Summary
Carney complex is a rare familial disease characterized by a
predisposition to develop multiple endocrine tumors and
highly morbid syndromes due to endocrine overactivities.
Its most frequent endocrine manifestation, hypersecretion
of glucocorticoids i.e. Cushing’s syndrome, is caused by
micronodular adrenal gland hyperplasia, an unusual
neoplasia which combines both hyperplastic and atrophic
areas. Inactivating mutations of the gene encoding the
regulatory subunit 1a (R1a) of the cAMP–dependent
protein kinase were frequently found in these patients,
but the causal link between loss of R1a and onset of this
adrenal disorder had not yet been established. Here, we
describe the first mouse model mimicking this disease and
provide mechanistic insights into endocrine overactivity
and neoplastic transformation. Indeed, we show that lack
of R1a induces autonomous expression of genes involved
in steroid biosynthesis and resurgence of hyperplastic
fetal-like cells with concomitant defects in cell renewal of
the adult cortex. Our data therefore represent a substantial
conceptual advance on the cellular dynamics involved in
adrenal gland homeostasis. They suggest that regression
of fetal structures may be important to establish normal
endocrine functions and to allow cell renewal in the
definitive cortex. Failure to clear out cells of fetal features
in R1a-deficient adrenals leads to morbid hyperplasia.
R1a Loss and Adrenal Hyperplasia
PLoS Genetics | www.plosgenetics.org 2 June 2010 | Volume 6 | Issue 6 | e1000980Figure 1. Generation of a conditional knockout for Prkar1a in mouse adrenal cortex (AdKO mice). (A) Scheme of the 0.5 Akr1b7-Cre
transgene driving the Cre expression in adrenal cortex, the Prkar1a floxed allele: Prkar1a
loxP and the knockout Prkar1a allele lacking exon 2: Prkar1a
D2.
Black rectangles, exons; white triangles, loxP sites; small arrows, primers used for genotyping (see Materials and Methods for details). (B) Genomic PCR
experiments using primers a, c and b, c (see A) were performed to confirm all the genotypes. Corresponding phenotypes are indicated. Intact floxed
allele was amplified using primers b and c and knockout allele was amplified using primers a and c. (C) Levels of the different PKA subunits were
quantified by western blotting in adrenals of 10-month-old WT vs AdKO parous female mice. * P,0.05; ** P,0.01. (D) Top panels: In situ hybridization
of adrenal tissue from WT (left) and AdKO (middle and with haematoxylin/eosin staining in the right) parous female mice (10-month-old) with Prkar1a
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R1a did not impair ACTH inducibility of steroidogenesis (Figure
S3). Altogether, these data demonstrated that the adrenal glands of
AdKO mice acquired the ability to secrete corticosterone in an
autonomous manner leading to frank (in females) or subclinical (in
males) ACTH-independent Cushing’s syndrome.
Adrenal cortex-specific ablation of Prkar1a increases PKA
signalling
Glucocorticoid biosynthesis depends on the continuous ACTH
stimulation of adrenal steroidogenic and detoxification genes,
through the cAMP/PKA signalling pathway. We thus studied the
expression level of ACTH-dependent (Star, Akr1b7, Cyp11a1,
Cyp11b1) and -independent (Cyp11b2) genes in WT and AdKO
adrenal glands (Figure S4). RT-QPCR showed that basal
hypercorticosteronaemia found in 10 months AdKO females
correlated with a significant increase in Star mRNA levels (Figure
S4B). A corresponding rise of StAR protein accumulation was
confirmed by western blot (Figure S4B, inset). Consistent with
their milder phenotype, males did not show any significant change
in the expression of steroidogenic genes. By contrast, when AdKO
mice with subclinical Cushing’s syndrome (5-month-old females
and 10-month-old males) were submitted to dexamethasone
suppression test, most of the ACTH-responsive genes remained
upregulated when compared to WT (Figure S4C). As expected,
Cyp11b2 gene expression remained unchanged, showing that this
response of mutant mice depended on ACTH signalling. We then
checked whether Prkar1a ablation in AdKO mice led to the
expected increase in PKA signalling, by measuring the PKA kinase
activity and CREB phosphorylation on ser133 residue. Kinase
assays demonstrated that basal PKA activity (in the absence of
cAMP) was increased in mutant adrenals while total activity (in the
presence of cAMP) remained unchanged (Figure 3A). In
agreement with an increase in basal PKA activity, the amount
of P-CREB in AdKO adrenals was doubled when compared to
WT (Figure 3B). All these converging data demonstrated that the
adrenal cortex-specific ablation of the Prkar1a gene led to primary
pituitary-independent hypercorticosteronaemia through enhance-
ment of PKA signalling.
AdKO mutant mice show adrenal hyperplasia and
zonation defects
Histological abnormalities consisting of large eosinophilic fœtal-
like cells emerging from the innermost part of the adrenal cortex
were detected in 5-month-old AdKO mice (Figure 4A and 4D).
Eosinophilic cells appeared clearly hypertrophic when compared
to WT spongiocytes (229642 mm
2 vs 110615, p,0.01) (Figure 4H
and 4K, insets). This hypertrophic cell population expanded
centrifugally to represent more than 50% of the cortex at 10
months (Figure 4B and 4E) and most of the cortex by 18 months
(Figure 4C and 4F). Simultaneously, neighbouring zona fasciculata
cells, still arranged in tighly packed cords in 5-month-old mutant
mice, became gradually disorganized in 10-month-old adrenals
and appeared completely atrophic at 18 months (Figure 4G–4L).
At this stage, the zona glomerulosa no longer appeared as a
continuous layer of cells but as groups of glomeruli, isolated from
each other by small hyperplastic spindle-shaped basophilic cells,
arising from the subcapsular region (Figure 4L). This region
contains adrenal stem/progenitor cells ensuring the continuous
renewal of the adult cortex [14–16]. We thus assessed possible
changes in the contents of adrenocortical progenitors in AdKO
females of 10 and 18 months of age by quantifying expression of
the progenitor-specific marker Shh and Gli1 [16] and the potential
stem cell marker Pod1 [17]. RT-QPCR analyses showed that
expression of these genes were not affected by the genotype nor the
age (Figure S5), suggesting that the number of adrenocortical
progenitors may not be affected in AdKO mice. The different cell
populations in this area were characterized by double immuno-
staining for Sf1, a marker of steroidogenic lineage, and for b-
catenin, a marker of subcapsular steroidogenic lineage mostly
represented by zona glomerulosa cells [18]. Double immunostaining
of WT adrenals from 18-month-old mice confirmed that both
markers (Sf1 staining in the nucleus and b-catenin mostly at the
cell periphery) colocalized in the cells of zona glomerulosa that
formed a continuous layer in the outermost cortex (Figure 4M). By
contrast, in age-matched AdKO adrenals, the general disorgani-
zation of the innercortex (Sf1-positive, b-catenin-negative cells)
and the discontinuous aspect of the subcapsular/glomerulosa zone
(Sf1/b-catenin-positive cells) were obvious (Figure 4N). A detailed
view of this area showed hyperplastic spindle-shaped cells, both
Sf1- and b-catenin-negative, were surrounding the Sf1- and b-
catenin-positive glomeruli (Figure 4O). In previous mouse models
for adrenocortical tumours, the first signs of neoplastic transfor-
mation seemed to coincide with the emergence of Gata-4 positive
cells growing centripetally from the subcapsular region [15]. Thus,
we examined expression of this transcription factor by immuno-
staining on 18-month-old adrenal sections. As shown in Figure 4P-
4Q, numerous cells with Gata-4 nuclear staining could be detected
within the subcapsular hyperplastic region of AdKO adrenals
while, as expected, very rare positive cells were observed in WT.
To determine the mechanisms leading to early hyperplasia of
the large eosinophilic cells and late hyperplasia of the small
spindle-shaped cells, cellular proliferation within adrenal glands of
5–18 months mice was assessed by immunodetection of Ki67
(Figure 5A). At 5 or 10 months, WT and AdKO adrenals did not
show any difference in the number of Ki67 positive cells (not
shown). By contrast at 18 months, the number of proliferative cells
was more than doubled in mutant adrenal cortex. All Ki67-
positive cells were also and thus probably corresponded to the
large eosinophilic cells but not to the Sf1-negative small spindle-
shaped cells (Figure 5B). The increased cell proliferation was only
evident in late stage of the AdKO phenotype and then could not
be sufficient to explain the hyperplasia of innercortex observed in
5-10-month-old mice. We thus tested the sensitivity of adrenocor-
tical cells to apoptosis induced by dexamethasone injections in 5-
month-old mice [19]. Although apoptotic cells, assessed by positive
staining for cleaved caspase 3, were detected within the cortex of
both genotypes upon dexamethasone treatment, adrenal sections
from AdKO mice showed 62% less apoptotic cells than WT
(Figure 5C). These data support the view that early hyperplasia
observed in 5-10-month-old AdKO mice could be, at least in part,
the result of decreased sensitivity to apoptosis. TGFb superfamily
members inhibin and activin play a critical role in the growth
dynamics of transient zones in the developing adrenal of both
human and mouse [20,21]. The expression of genes encoding the
activin subunits (Inhba and Inhbb), the inhibin subunit (Inha) and
the activin-binding protein follistatin (Fst) were compared in WT
and AdKO adrenals (Figure 5D). The mRNA levels of inhibin
subunit and follistatin were 2-fold higher in AdKO adrenals
antisense riboprobe. Lower panels: R1a protein was immunodetected in adrenal sections of WT (left) and AdKO (right) 18 month-old parous females.
Arrows in AdKO indicate some of the few cortical cells in which Prkar1a expression is maintained. Scale bars, 50 mm.
doi:10.1371/journal.pgen.1000980.g001
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assess the relevance of this observation in the human adrenal, we
realised an immunostaining against INHIBIN-a on sections from
normal (3 patients) and PPNAD-affected adrenocortical tissues (5
patients) (Figure 5E and Figure S6). Hypertrophic cells that form
the nodules were strongly stained. By contrast, no significant signal
Figure 2. AdKO mice exhibited an age-dependent, dexamethasone-resistant increase in plasma corticosterone. (A) Abnormal
accumulation of adipose tissue (dotted white line) in the back of AdKO females (10-month-old). (B) Quantitative analysis of plasma corticosterone in
WT female mice compared to AdKO at 5, 10 and 18 months. (C) Mean adrenal weights of 5-month-old WT and AdKO female mice (parous) in basal
conditions or after 4 days dexamethasone suppression test. (D) Representative haematoxylin and eosin adrenal staining in the same conditions as (C).
Scale bars, 50 mm. (E) Quantitative analysis of plasma corticosterone in basal conditions or after dexamethasone suppression test, in 5-month-old
parous females and 10-month-old males WT mice compared to AdKO mice. * P,0.05; ** P,0.01.
doi:10.1371/journal.pgen.1000980.g002
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fasciculata nor in sections of normal adrenal tissues. Hence, in both
mice and humans, R1adepletion in adrenal cortex led to increased
expression of TGFb members known for their antagonistic effects
on apoptotic action of activins [22].
Adrenal specific ablation of Prkar1a leads to resurgence
of foetal features
Adrenocortical-specific ablation of the Prkar1a gene led to
expansion of hypertrophic eosinophilic cells emerging from the
innermost part of the cortex, adjacent to adrenal medulla
(Figure 4). We hypothesized that this cell population could
originate from the X-zone, a transient zone of fœtal origin that
regresses during the first pregnancy in female and at puberty in
male mice [23,24]. Hence, we compared adrenal zonation in WT
and mutant mice by using Akr1b7 and 20a-HSD immunostaining
to delineate zona fasciculata and X-zone, respectively [25,26]
(Figure 6 and Figure S7). Adrenal cortex from WT virgin females
showed canonical concentric organization consisting of three
adjacent zones: X-zone (20a-HSD-positive and Akr1b7-negative),
zona fasciculata (20a-HSD-negative and Akr1b7-positive) and zona
glomerulosa (20a-HSD-negative and Akr1b7-negative) (Figure 6A).
By contrast, in the adrenal gland of 5-month-old AdKO virgin
females although the 20a-HSD-expressing cells remained adjacent
to the medulla, the X-zone and zona fasciculata were now
overlaping in the innermost part of the cortex, and some isolated
cells co-expressed both 20a-HSD and Akr1b7 markers (Figure 6B).
As expected, in 10-month-old parous WT females, X-zone had
completely regressed and 20a-HSD-expressing cells were no
longer detected (Figure 6C). By contrast, adrenal cortex from
age-matched parous AdKO females showed a persistent large X-
like-zone that has clearly expanded in a centrifugal direction
(Figure 6D). At this stage, most 20a-HSD positive cells of the X-
like-zone also expressed Akr1b7 and the typical packed cords
organization of zona fasciculata was no longer observed in the
Akr1b7-positive/20a-HSD-negative remaining cortex. In 18-
month-old females, the X-like-zone had further expanded and
now represented most of the cortex. Akr1b7-positive/20a-HSD-
negative cells were repelled to adrenal periphery (Figure 6E).
Interestingly, examination of the proliferative potential of the X-
like-zone using double immunostaining showed that Ki67-
positive/20a-HSD-positive cells could be found in both 10 and
18-month-old AdKO females (Figure S8).
Many 20a-HSD positive cells were also detected in 18-month-
old AdKO males although the observed phenotype was milder
than in females (Figure S9). Indeed, most 20a-HSD-expressing
cells were not Akr1b7-positive and the overlap of X-like-zone with
zona fasciculata was limited to the innermost cortex. In mouse,
natural X-zone regression at puberty can be suppressed by
castration of pre-pubescent males. To explore the possible reasons
Figure 3. PKA activity was increased in AdKO adrenals. (A) In vitro quantification (arbitrary units) of the PKA catalytic activity in adrenal
extracts of 10-month-old WT and AdKO females. The activity was positively or negatively regulated by cAMP, the ligand of regulatory subunits, and/or
PKI, a selective inhibitor of the PKA catalytic subunits, respectively. ** P,0.01. (B) Representative CREB/P-CREB western blotting and quantification of
the CREB protein phosphorylation in 10 months WT and AdKO adrenals. * P,0.05.
doi:10.1371/journal.pgen.1000980.g003
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PLoS Genetics | www.plosgenetics.org 6 June 2010 | Volume 6 | Issue 6 | e1000980Figure 4. Morphological defects and progressive hyperplasia in AdKO adrenals. (A–L) Adrenals were collected from WT (A–C and G–I) and
AdKO (D–F and J–L) parous females aged of 5, 10 and 18 months and stained with haematoxylin and eosin. AdKO adrenal cortex presented
progressive centrifugal expansion of large eosinophilic cells, indicated by a double arrow in (D–F). In the top panels, squares delineate the higher
magnifications shown in (G–I) for WT and (J–L) for AdKO adrenals. Insets, higher magnification illustrating the increased cell area of expanding
eosinophilic cells compared to normal spongiocytes. (M–O) Adrenal sections from 18-month-old mice double-stained for b-catenin, a zona
glomerulosa marker (in green) and for Sf1, a steroidogenic marker (in red). Nuclei were stained by Hoechst in blue. (M) WT adrenal cortex. (N) AdKO
adrenal cortex. (O) Higher magnification of (N), where hyperplastic small spindle-shaped, basophilic cells lacking both staining are enlightened by
arrows. (P–R) Immunodetection of the pre-tumoural marker Gata-4 in adrenal sections of parous 18-month-old females. (P) WT. (Q–R) AdKO. (R) The
square delineates the higher magnifications shown in the right. Top panel: Gata-4 staining. Lower panel: same section with haematoxylin and eosin
counter-staining. M, Medulla; C, Cortex; F, zona fasciculata;G ,zona glomerulosa; Ca, Capsule; Scale bars, 50 mm.
doi:10.1371/journal.pgen.1000980.g004
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PLoS Genetics | www.plosgenetics.org 7 June 2010 | Volume 6 | Issue 6 | e1000980Figure 5. Proliferation and resistance to apoptosis in AdKO adrenals, inhibin-activin system in AdKO adrenals, and PPNAD. (A)
Adrenals from 18-month-old WT and AdKO parous females were immunodetected with Ki67 proliferation marker. The corresponding statistical
analysis of the number of Ki67 expressing cells in the adrenal cortex of both genotypes is shown on the right panel. ** P,0.01. (B) Co-
immunodetection of Ki67 (green) and Sf1 (steroidogenic marker, red) in 18 months AdKO adrenal sections. Co-localisation of Ki67 and Sf1 stainings is
shown in the right panel. (C) Representative stainings for cleaved-caspase 3 apoptosis marker in WT and AdKO adrenal sections of 5-month-old mice
treated for 4 days with dexamethasone. The right panel shows the quantification of apoptotic cells (cleaved-caspase 3 positive) in adrenal cortex of
untreated (Ctrl) or treated (Dexa) mice of both genotypes. * P,0.05. (D) Quantitative representation of mRNA expression (RT-QPCR) of genes
encoding inhibin-activin system in 10-month-old parous female adrenals of both genotypes. Inhibin subunit (Inha); Activin A and B subunits (Inhba
R1a Loss and Adrenal Hyperplasia
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whether gonadectomy occuring at 3-weeks of age (before natural
X-zone regression) could accelerate the onset of the adrenal
defects in 3-month-old adult males (Figure S10). 20a-HSD/
Akr1b7 co-immunostaining showed that castration allowed the
maintenance of a classical X-zone in WT, and of a X-like-zone
overlaping fasciculata in AdKO adult males. When compared to
shame-operated AdKO males of the same age, gonadectomized
AdKO males showed a high number of Akr1b7-positive/20a-
HSD-positive cells, these cells being never observed in gonadec-
tomized WT males (Figure S10A). Consistently, corticosterone
levels were more elevated in gonadectomized than in shame-
operated AdKO males (Figure S10B). By contrast, gonadectomy
had no impact on corticosterone levels in WT males. These data
suggested that gonadectomy was able to amplify the phenotype in
male AdKO mice.
The persistence of X-zone marker suggested that foetal
characteristics were maintained throughout adult life of AdKO
mice. Cyp17 is a steroidogenic enzyme involved in the biosynthesis
of precursors of both sex steroids and cortisol. In rodents, however,
Cyp17 is only transiently expressed in the foetal adrenal and is
therefore considered a foetal marker [27]. RT-QPCR analyses
showed that, as opposed to WT, most adult AdKO adrenal glands
expressed high levels of Cyp17 transcripts (Figure 7A). In addition,
Cyp17 positive immunostaining was detected within the inner-
cortex of AdKO adrenal glands (Figure 7B). More importantly,
this expression led to the production of a functional Cyp17 enzyme
since AdKO mice produced detectable levels of cortisol
(Figure 7C). Because both corticosterone and cortisol production
required the continuous expression of genes encoding Cyp21 and
Cyp11b1 biosynthetic enzymes, we examined whether their
expressions were maintained throughout the progression of the
AdKO phenotype (Figure S11). RT-QPCR analyses demonstrated
that Cyp21 and Cyp11b1 expression levels were unchanged with
age in both WT or AdKO females.
Altogether, these data demonstrate that adrenal-specific abla-
tion of Prkar1a altered the differentiation program of the adult
cortex by promoting the improper maintenance and centrifugal
expansion of steroidogenic competent foetal-like cells, that had the
capacity to proliferate and to produce glucocorticoids (cortisol and
corticosterone).
Discussion
Here, we shown that the adrenal-specific ablation of Prkar1a, the
Carney Complex gene 1 (CNC1), in mouse reproduced the
essential features of PPNAD observed in humans carrying
PRKAR1A mutations. AdKO mice developed ACTH-independent
Cushing’s syndrome and cortical hyperplasia combined with
atrophic areas that are typical hallmarks of PPNAD [1]. This
mouse model definitively proves the central role of PRKAR1A gene
defects in the etiology of PPNAD. Furthermore, the discovery of
an unexpected role of Prkar1a in the repression of foetal features in
adrenal cortex provides novel mechanistic insight into the cellular
dynamics leading to definitive adrenal tissue or, when disturbed, to
morbid hyperplasia.
AdKO mice phenocopied most of the features of adrenal
overactivity seen in patients. From a clinical point of view, PPNAD
is difficult to diagnose because Cushing’s syndrome usually
develops slowly. Hypercortisolism may be mild or even periodic,
with no clear decrease in plasma ACTH levels [28–30]. Adrenal-
specific disruption of Prkar1a triggered subclinical hypercorticos-
teronaemia revealed upon blockade of pituitary ACTH, in 5-
month-old mice. Around one year of age, it evolved into frank
Cushing’s syndrome with low, but still detectable levels of plasma
ACTH. Contrasting with PPNAD, we did not detect any
paradoxical rise in corticosterone levels after dexamethasone
injection in AdKO mice, but only a resistance to ACTH blockade.
Paradoxical response would rely on increased expression of the
glucocorticoid receptor (GR) that was shown to activate PKA in
PPNAD nodules [31,32]. We did not find any AdKO-dependent
increase in GR expression neither by measuring mRNA levels nor
by immunohistochemical analyses (not shown). This paradoxical
response could likely be a feature of human cells since adrenal
cultures from Prkar1a haploinsufficient mice did not show
paradoxical dexamethasone response in perifusion experiments
[32]. Another discrepancy between AdKO adrenals and PPNAD
was the absence of pigmentation in the mice glands. Hyper-
pigmentation in PPNAD nodules relies on the accumulation of
lipofuscin and is a consequence of autophagic deficiency [33,34].
This decreased autophagy was thought to originate from the R1a
loss and consecutive activation of mTOR signalling [35].
Lipofuscin is made of aldehyde-linked protein residues that make
it non-degradable and that form under chronic mild oxidative
stress conditions, at a rate inversely related to the average lifespan
of species [36]. We thus speculate that more efficient enzymatic
defenses against reactive aldehydes forming aducts [25] and/or
shorter lifespan might preserve mice from adrenal lipofuscin
accumulation under R1a depletion. The cytomegalic aspect of
eosinophilic cells arising from the innercortex is a hallmark of
hyperplasia seen in PPNAD patients or in AdKO mice, and could
be linked to unbuffered mTOR activity [35,37] that is a
prerequisite to increased cell size [38]. Works are in progress to
explore the contribution of this pathway in the pathophysiology of
the AdKO model.
Although they were attributed to the lack of R1a regulatory
subunit of PKA, until now, the mechanisms leading to adrenal
overactivity in PPNAD were not clear. The PKA heterotetrameric
holoenzyme is composed of a dimer of regulatory subunits
combined with two catalytic subunits. When the regulatory
subunits bind cAMP, they dissociate from the catalytic subunits,
which in turn, exhibit their kinase activity [39]. In previous
knockout mouse models with general loss of R1a, basal PKA
activity (linked to free catalytic subunits only) measured in embryos
was found increased whereas total PKA activity (cAMP-stimulat-
ed) was decreased [5]. When measured in mouse embryonic
fibroblasts both activities were increased [40]. The net impacts of
R1a depletion on PKA activity could therefore depend on the cell
type or tissue context. Consistent with these studies, specific
depletion of R1a in adrenals mainly triggered a rise in basal PKA
activity, attested both by increased catalytic activity and CREB
phosphorylation. This resulted in a net gain of Star gene expression
and therefore increased basal steroidogenesis. In agreement with
our findings, StAR gene expression was found upregulated in a
serial analysis of gene expression (SAGE) of PPNAD tissues [41].
and Inhbb); Follistatin (Fst). * P,0.05; ** P,0.01. (E) Immunostaining for INHIBIN-a on human adrenal sections from control G52902 patient (female)
and PPNAD G91567 patient (female) carrying germline PRKAR1A-inactivating mutation c.709-7del6(TTTTTA) [61]. Similar stainings were observed on
two other control patients (not shown) and four other PPNAD patients (Figure S6). Square delineates the higher magnifications located on the right.
N, nodule; M, medulla, F, zona fasciculata. Scale bars, 15 mm in entire human adrenal and 50 mm in magnification.
doi:10.1371/journal.pgen.1000980.g005
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AdKO mice was an atypical hyperplasia of foetal-like cortex
emerging at the corticomedullary junction which, over time,
extended to the periphery. However, concomitant atrophy of the
adult cortex resulted in net adrenal size equivalent to WT. These
results were reminiscent of early histopathological studies of
Figure 6. Existence of a persistent, mislocated X-like-zone in AdKO adrenals. The X-zone 20a-HSD marker (in red) and the zona fasciculata
Akr1b7 marker (green, right column) were co-immunodetected. The two colours are merged in the right column with the Hoechst nuclei marker
(blue). (A) Adrenal section of a 5-month-old nulliparous WT female. The unlabelled zone separating the X-zone (red) and the zona fasciculata (green)
is indicated by a star (*). (B) Adrenal section of a 5-month-old nulliparous AdKO female. (C) Adrenal section of a 10-month-old parous WT female. (D)
Adrenal section of a 10-month-old parous AdKO female. (E) Adrenal section of a 18-month-old parous AdKO female. M, Medulla; F, zona fasciculata;G ,
zona glomerulosa; X, X-zone; XL, X-like-zone; Scale bars, 50 mm.
doi:10.1371/journal.pgen.1000980.g006
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medulla-cortex boundary. These were composed of eosinophilic
giant cells that were surrounded by mostly atrophic cortex
resulting in an otherwise normal-sized gland [1,42,43]. In mice,
a transient cell layer, termed the X-zone, is adjacent to the
medulla and regresses at puberty in males and at the first
pregnancy in females [23]. Pioneer work from Morohashi‘s
laboratory provided unequivocal genetic proofs that the X-zone
was a remnant of foetal cortex forming before the definitive cortex
and that distinct pools of precursor cells within the foetal cortex
contributed to either the definitive cortex or the transient X-zone
[24,44]. One pool of precursors activated transiently the foetal
adrenal-specific enhancer of Ad4BP/Sf1 (FAdE) and contributed to
the definitive cortex while the second pool maintained FAdE
activated and contributed to the formation of the transient X-zone
[24]. We showed previously that the developmental pattern of
Akr1b7-Cre mediated recombination was reminiscent of that
observed with the FAdE construct and that it occurred in both
foetal and definitive adrenocortical cells [13]. Here, we provided
evidence that loss of R1a during adrenal development resulted in
two major abnormalities: unbuffered PKA activity leading to
endocrine overactivity, and persistence of foetal-like cells that
expanded across the adult cortex. In human, INHIBIN-a is more
expressed in foetal than in adult adrenals [45]. In PPNAD, besides
the hypertrophic aspect of the cells, the overexpression of
INHIBIN-a specifically in the nodules could be interpreted as
another sign of foetal origin of these cells. In mice, the foetal
character of these hyperplastic and hypertrophic cells was attested
both by persistent expression of 20a-HSD, an X-zone marker, and
by re-expression of Cyp17, an enzyme otherwise restricted to the
embryonic period in rodent adrenals [26,27]. However, in contrast
to natural X-zone cells that had no reported steroidogenic
potential, the foetal-like hyperplastic cells of AdKO adrenals had
acquired full steroidogenic competence of zona fasciculata cells and
produced both corticosterone and cortisol. It is tempting to
speculate that this (hyper)cortisolism, hitherto never described in
mouse, could participate to the Cushing’s syndrome of AdKO
mice.
Our data demonstrated that AdKO adrenals were less sensitive
to apoptosis than WT. Apoptosis mediated by TGFb family
members largely contributed to the regression of both human
foetal zone and mice X-zone in which both inhibin and follistatin
opposed to the apoptotic signal triggered by activins [20,21]. This
is in good agreement with our observation that inhibin-follistatin/
activin transcripts ratio was augmented in AdKO adrenal glands
and could therefore contribute to strengthen anti-apoptotic
paracrine signals. In addition, R1a depletion could render foetal
cells less sensitive to TGFbsignalling. This mechanism likely
occured in human cells since we recently demonstrated that R1a
knockdown in NCI-H295R adrenocortical cells enhanced their
resistance to TGFb-stimulated apoptosis [46]. Consistent with all
these observations, here we showed an increased immunostaining
for INHIBIN-a specifically in the nodules of PPNAD samples.
Converging data in the literature highlight the importance of
inhibin/activin system as a paracrine mediator of cAMP/ACTH
signalling in both foetal and adult tissues [20,47–49]. Accordingly,
maintaining derepression of PKA activity in the adrenal glands of
AdKO mice from the foetal period to adulthood would favour the
maintenance of high levels of inhibin. Interestingly, in a murine
cell line postulated to originate from the X-zone [50], inhibin was
shown to counteract the repressive effect of activin on the Cyp17
gene [51]. This could provide a plausible but yet-non-demon-
strated mechanism for re-expression of Cyp17 in the adult mutant
gland of AdKO mice.
Most adrenocortical tumours and Cushing’s syndrome are more
frequent in females than in males [52]. PPNAD does not escape
this rule [12]. By the age of 40 years, more than 70% of the female
carriers of PRKAR1A defects had clinical evidence of this disease,
Figure 7. AdKO adrenals expressed Cyp17 and produced cortisol. All the experiments were realised in 10-month-old parous females. (A)
Quantitative representation (RT-QPCR) of Cyp17 mRNA levels, a foetal adrenal marker in mouse, in WT and AdKO adrenals. (B) Representative
immunodetection of Cyp17 showing abnormal expression in the innercortex in AdKO compared to WT adrenals. (C) Quantitative analysis of plasma
cortisol showing significant level of cortisol in AdKO compared to normal absence in WT mice. * p,0.05.
doi:10.1371/journal.pgen.1000980.g007
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addition, PPNAD was diagnosed at a younger age in females than
in males. These clinical outcomes were strikingly reminiscent of
the phenotype of AdKO mice that was earlier and more severe
(Cushing’s syndrome and hyperplasia) in females than in males.
Although the influence of sex-specific hormones cannot be ruled
out as suggested by the (permissive) aggravating effect of
gonadectomy in AdKO males, some gender specificities of foetal
cortex cells could account for these differences in mouse. First,
foetal expression of Cyp17 was nearly completely down-regulated
at E14.5 in males, whereas down-regulation occurred only at birth
in females [53]. Second, post-natal foetal cortex, the X-zone,
regressed at puberty in males but only during first pregnancy in
females. Thus, foetal cells (and among them, foetal/X-zone
precursor cells) remained for a longer time in the female cortex.
Since our mouse model showed that R1a loss contributed to
foetal-like cortex persistence and expansion, it is reasonable to
assume that enrichment in foetal cells (or foetal precursor cells)
predisposes AdKO females to manifest more severe PPNAD. To
our knowledge, possible gender differences in foetal cortex
dynamic changes have never been addressed in human adrenals.
According to the centripetal model, cell renewal in the adrenal
cortex depends on a common pool of stem/progenitor cells
located in the periphery (within the fibroblastic capsule and/or the
glomerulosa) which migrate centripetally from this zone, differenci-
ate to successively adopt all the cortical fates and finally enter into
apoptosis in the innermost cortex (Figure 8). According to cell
lineage-tracing studies, two populations of progenitors contributed
to the formation of the adult cortex, one located in the capsule
expressed Gli1 and the second in a subcapsular position expressed
Shh [16]. Although the role of capsule/subcapsule in the
centripetal renewal of the adult definitive cortex is now fully
established, there are also genetic evidences that in developing
adrenal, the definitive cortex and the transient X-zone originate
from different foetal precursors [24,44].
According to the centripetal model, dividing cells are essentially
present at the periphery while apoptotic cells preferentially
concentrate at the inner cortex ([54], reviewed in [17]). The
balance between these two opposing gradients could be essential
for homeostatic maintenance of the adrenal cortex i.e. the
establishment of a centripetal differentiation. In AdKO mice, the
centrifugal expansion of foetal-like cells with proliferative potential
emerging from the inner cortex and the progressive atrophy of
zona fasciculata could indicate that this balance is perturbed. A
possible model may be proposed to illustrate these observations
(Figure 8). Indeed, loss of R1a allowed the maintenance of cells of
foetal features, which otherwise were transient. This maintenance
could result from both an improvement of their proliferative
capacity and from their decreased sensitivity to apoptotis and/or
alteration of the apoptotic gradient (as suggested by the increased
expression of Inha and Follistatin genes known to antagonise
activins signalling). In addition, loss of R1a induced a progressive
atrophy of the zona fasciculata in AdKO adrenals that was
reminiscent to defects in cell renewal. Indeed, whereas the
foetal-like cells undergo a continuous centrifugal expansion across
the cortex, no gain in adrenal size was detected and no increase in
cell apoptosis accompanied the concomitant atrophy of zona
fasciculata. On the other hand, hyperplasia of non-steroidogenic
subcapsular spindle-shaped cells was observed in elder mice (18
months) and their accumulation eventually affected the integrity of
zona glomerulosa. At least two non-exclusive mechanisms could
account for defective cell renewal in the definitive cortex of AdKO
mice: depletion of progenitor cells or impaired capacity of these
progenitors to undergo centripetal differentiation and clonal
replenishment of the cortex. The latter mechanism seems more
likely in our model. Indeed, the expression levels of markers for
Figure 8. Model of dynamic changes and cell renewal in the AdKO adult cortex. Left, model of cell renewal and homeostatic growth
maintenance of WT adrenal cortex (according to [17]). Hypothetical opposing gradients of proliferation and apoptosis leading to the set up of
centripetal differentiation are schematized. Right, consequences of the defect of apoptosis gradient on the cellular dynamics in AdKO cortex (5-, 10-,
and 18-month-old mice). Loss of R1a led to decreased apoptosis of foetal cells which were maintained, expanded across the cortex and differentiated
(acquired steroidogenic competences) while definitive cortex progressively regressed.
doi:10.1371/journal.pgen.1000980.g008
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suggesting that progressive atrophy of the definitive cortex was not
due to their depletion. Similar to observations made in most
mouse adrenal tumour models, with age, adrenal glands of AdKO
mice accumulated subcapsular Gata-4-positive spindle-shaped
cells that are supposed to descend from multipotent progenitors
capable to engage toward adrenal or gonadal fates [15,55,56]. In
AdKO mice, late accumulation of Gata-4-positive cells could
reflect an incapacity for the progenitor cells to properly
differenciate into adrenocortical cells. This would prevent efficient
renewal of the definitive cortex, which as a result, would become
atrophic over time. An other hypothesis emerges from a recent
report of Hammer and colleagues showing that inhibin-a
prevented aberrant proliferation and differentiation of subcapsular
adrenocortical progenitor cells [57]. Indeed, as opposed to Inha
2/
2 mice, adrenal glands of AdKO mice have increased inhibin-a
expression. This is consistent with PPNAD samples and could
therefore decrease proliferation/differentiation of progenitors. The
possible dual role for inhibin-a in enhancing survival of foetal cells
and impeding renewal of definitive cortex will have to be
demonstrated in AdKO mice in an Inha
2/2 context. In a
symmetric point of view, the slow but continuous centrifugal
expansion of hypertrophic foetal-like cells, would imply that a
reservoir of foetal cortex precursor cells could lay in the
juxtamedullary region and that differentiating steroidogenic foetal
cells could emerge and replenish the cortex (Figure 8). Lineage
tracing experiments will be required to confirm this hypothesis.
By developing a mouse model of PPNAD, we established for the
first time that Prkar1a, the Carney Complex gene 1, not only
controls adrenocortical endocrine activity but also prevents the
maintenance of foetal remnants. The loss of R1a acts, at least, by
increasing PKA activity and possibly by PKA independent effects
mediated through alteration of protein interactions that remain to
be deciphered [35,58]. The data existing in the literature and our
present results strongly suggest a role for the inhibin-activin
signalling pathway in the progression of the disease. Adrenal
hyperplasia observed in PPNAD is classified as a neoplastic lesion.
Although we showed that R1a loss induced tumoural conditions in
adrenal glands (resistance to apoptosis, cell hypertrophy, mild
proliferation), profound alterations in zonal differentiation and cell
renewal suggest that PPNAD should also be considered as a
developmental disease.
Materials and Methods
Human PPNAD tissue sections
Informed signed consent for the analysis of adrenal tissue and
for genetic diagnosis was obtained from the patients and the study
was approved by an institutional review board (Comite ´ Consultatif
de Protection des Personnes dans la Recherche Biome ´dicale,
Cochin Hospital, Paris). PPNAD paraffin sections were performed
from adrenal samples of patients with isolated PPNAD or PPNAD
with Carney complex who underwent bilateral adrenalectomy for
ACTH-independent Cushing’s syndrome. All patients carried
germline inactivating mutations of the PRKAR1A gene.
Animals and hormonal treatments
Animal studies were done in agreement with standards
described by the NIH Guide for Care and Use of Laboratory
Animals as well as with the local laws and regulations applicable to
animal manipulations in France. For all analyses, groups of 17–20
mice of each genotype (WT and AdKO) and each age (5, 10 and
18 months) were constituted. Adult mice were injected s.c. with
vehicle (sesame oil), dexamethasone acetate for 4 days (75 mg twice
daily; Sigma-Aldrich, L’Isle d’Abeau Chesnes, France) and
injected i.m. with long-acting ACTH (1.2 U, Synacthene, Novartis
Pharma S.A., Rueil-Malmaison, France) the day before and in the
morning of the experiment.
Mouse genotyping
Mouse genomic DNA (from tail, adrenal or gonad) was
extracted and analyzed by PCR. Genotyping for the 0.5 Akr1b7-
Cre transgene was carried out using the following conditions:
94uC, 45 s; 55uC, 45 s; 72uC, 45 s for a total of 40 cycles (primers:
59-CCTGGAAAATGCTTCTGTCCG-39;5 9-CAGGGTGTTA-
TAAGCAATCCC-39) and Prkar1a
loxP/loxP intact or knockout allele
were genotyped using the following conditions: 94uC, 90 s; 58uC,
90 s; 72uC, 90 s for a total of 35 cycles (primer a:5 9-
CACTGCAGGGGCCTATTTTA -39; primer b:5 9-
TGTCTAGCTTGGGGTGGACT-39, primer c:5 9-CATC-
CATCTCCTATCCCCTTT-39).
Analysis of hormone levels
Mice were sacrified by decapitation at 8–9 am with minimum
handling (within 1 min), trunk blood was collected in eppendorf
tubes containing 5 mL EDTA 0.5 M and placed immediately at
4uC. Samples were spun down at 4000 g for 5 min at 4uC and the
resultant plasma was stored at 220uC for corticosterone or cortisol
analysis, or at 280uC for ACTH analysis.
Corticosterone concentrations in plasma were determined by
radioimmunoassay (RIA) using a commercially available kit (ICN
Biomedicals, Orsay, France). ACTH dosage in plasma were
performed by solid-phase, two-site sequentiel chemiluminescent
immunometric assay (Siemens Healthcare Diagnostic SAS, Saint-
Denis, France) using an Immulite 2000 analyzer. Cortisol
concentrations were determined by electrochemiluminescence
immunoassay (Roche Diagnostic, Meylan, France) using a
Modular Analytics E170 analyzer.
PKA activity
PKA activity was quantified in freshly dissected adrenals using
the following commercial kit: PepTag assay for non-radioactive
detection of cAMP-dependant protein kinase (Promega Corp.,
Charbonnie `re, France).
Quantitative reverse-transcription polymerase chain
reaction
Total RNA and DNA (for genotype confirmation) were isolated
from tissue with the Qiagen DNA/RNA Mini kit (Qiagen,
Courtaboeuf, France). Total RNAs (1 mg) were reverse-transcribed
by Moloney murine leukaemia virus reverse transcriptase
(Promega Corp., Charbonnie `re, France) according to the
manufacturer’s instructions. Quantitative real-time PCR was
performed using the iCycler BioRad system and BioRad IQ5
optical system software (BioRad, Marnes-la-Coquette, France)
under standard conditions (40 cycles of 95uC for 15 seconds and
60uC for 60 seconds). All primer/probe sets were obtained from
Applied Biosystems: Prkar1a, Prkar1b, Prkar2a, Prkar2b, Prkaca, Star,
Akr1b7, Cyp11a1, Cyp11b1, Cyp11b2, Cyp21, Shh, Gli-1, Pod-1, Ppib,
Cyp17, Inha, Inhba, Inhbb, Fst (Applied Biosystems, Courtaboeuf,
France). For quantification of transcripts, all PCR were performed
in triplicate and the DCt method was used to calculate mRNA
levels relative to a Peptidylprolyl isomerase B (Ppib) standard.
In situ hybridization
A 442 bp 39untranslated part of the Prkar1a cDNAs was
amplified using the following primers: 59-GGGCGTTGGAAT-
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subcloned in pGEM-T easy vector (Promega Corp., Charbon-
nie `re, France). Antisense riboprobes were synthesized and labelled
with digoxigenin (Boehringer Mannheim, Mannheim, Germany).
Adrenals were fixed in 4% paraformaldehyde overnight, embed-
ded in paraffin and sectioned. Sections were treated for 15 min
with proteinase K (3 mg/ml) at room temperature and washed
with glycine (2 mg/ml) and then with PBS. They were fixed with
4% paraformaldehyde for 5 min and washed with PBS. Samples
were incubated in hybridization mix (50% formamide; 4x SSC;
10% Dextran sulphate; 1x Denhart’s; Salmon sperm DNA
250 mg/ml; tRNA 250 mg/ml) for 1 h at 42uC. Digoxygenin
labelled probe was added to the hybridization mix and incubated
overnight at 42uC. Slides were then treated to a series of washes in
2x SSC and 1x SSC at 42uC and 0.2x SSC at room temperature.
Sections were washed in buffer 1 (150 mM NaCl; 100 mM Tris,
pH 7.5), blocked by Boehringer blocking reagent in buffer 1 then
incubated 1 h at room temperature with peroxidase-conjugated
anti-digoxygenin antibody. After several washes in buffer 2
(150 mM NaCl; 100 mM Tris, pH 9.5; 5 mM MgCl2), peroxidase
activity was detected by incubation with 0.18 mg/ml BCIP and
0.34 mg/ml NBT in buffer 2. In situ hybridization slides were
observed and photographed on an Axiophot microscope (Carl
Zeiss, Zurich, Switzerland).
Histology and immunostaining
Adrenals were fixed overnight in 4% PFA and embedded in
paraffin. Sections were then cut and deparaffinized in Histoclear.
For general morphology, sections were stained with haematoxylin
and eosin.
For mouse-anti-human-INHIBIN-a immunodectection, un-
masking solution was sodium citrate buffer 10 mM pH 6, Tween
0.05%. For co-localisation experiments of Akr1b7/Ki67 with 20a-
HSD, the following protocol of limit detection was used:
deparaffinised sections were incubated for 20 min at 95uC with
Unmasking Solution (Vector Laboratories, Peterborough En-
gland). For the first detection, rabbit-anti-Akr1b7 antibody [59]
(1/1000) or rabbit-anti-Ki67 (1/500, Thermo Fischer Scientific,
Elancourt, France) was revealed using a secondary biotinylated
goat anti-rabbit antibody, Vectastain ABC amplification kit
(Vector Laboratories, Peterborough England) and TSA fluorescein
HRP substrate (Perkin Elmer, Courtaboeuf, France). For the
second detection, slides were incubated with a rabbit-anti-20a-
HSD antibody at 1/2000 (kind gift from Dr Y. Weinstein, Ben-
Gurion University, Israe ¨l) revealed by goat anti-rabbit Alexa 555
at 1/1000 (Molecular probes, Cergy Pointoise, France). Sections
were then incubated 5 min with Hoechst at 1 mg/ml (Sigma-
Aldrich, L’Isle d’Abeau Chesnes, France), rinsed, mounted in
PBS-glycerol, and photographed on an Axiophot microscope (Carl
Zeiss, Zurich, Switzerland).
The following antibodies: Mouse-anti-R1a (1/50, BD Biosci-
ences, Le pont de Claix, France); rabbit-anti-Sf1 (1/1000, kind gift
from Dr K. Morohashi, Kyushu University, Japan), rabbit-anti-
Cyp17 (1/5000, kind gift from Dr A. Conley, University of
California, USA); rabbit-anti-cleaved-Caspase-3 (1/400, Cell
signalling, Saint-Quentin-en-Yvelines, France); goat-anti-GATA-
4 (1/100, Tebu-Santa Cruz, Le Perray en Yvelines, France),
mouse-anti-b-catenin (1/500, BD Biosciences, Le pont de Claix,
France), mouse-anti-human-INHIBIN-a (1/75, AbD Serotec,
Oxford, UK) were detected using the same protocol as Akr1b7.
The secondary biotinylated antibodies were donkey anti-goat to
detect Gata-4 and sheep anti-mouse to detect R1a and b-catenin.
Gata-4 detection was performed using the Novared Kit (Abcys,
Paris, France).
For the double staining b-catenin/Sf1, 20 min in 0.02% HCl
are necessary to abolish the rest of the peroxidase activity after the
first immuno-reaction. Detection of Cyp17 was done without
incubation in unmasking solution. An InSitu Pro VSi (Intavis AG)
automated processor was used for immunodetection.
Western blot analysis
Adrenal samples and western blotting were done as described
previously [60]. The Primary antibodies were used at the following
dilutions: rabbit-anti-StAR (1/5000, kind gift from Dr Stocco,
Texas Tech University Health Sciences Center, USA); mouse-
anti-R1a (1/500); mouse-anti-R2a (1/1000); mouse-anti-R2b (1/
1000); mouse-anti-Cab (1/1000, BD Biosciences, Le Pont de
Claix, France), rabbit-anti-CREB (1/1000), rabbit-anti-P-CREB
(1:1000, Cell signalling, Saint-Quentin-en-Yvelines, France);
rabbit-anti-bTubulin (1/1000, Sigma-Aldrich, L’Isle d’Abeau
Chesnes, France). Quantification of western blot signals was
performed using the Quantity One software (Biorad, Marnes la
Coquette, France).
Statistical analysis
For statistical analysis, a Student t test was performed to
determine whether there were differences between the two groups.
Mann-Whitney test was used in Figure 7A. A P value of 0.05 was
considered significant.
Supporting Information
Figure S1 Quantification of mRNA levels of the PKA subunits
in 10-month-old, WT and AdKO mice adrenals. A, Quantitative
(RT-QPCR) representation of R1a subunit mRNA expression in
female (parous) and male adrenals of both genotypes. A significant
decrease was detected in AdKO when compared to WT, as
expected, ** p,0.01. Insets show levels of R1a subunit analysed
by western blotting in adrenals. B, Quantitative (RT-QPCR)
representation of mRNA expression of the different PKA subunits
in female adrenals of both genotypes.
Found at: doi:10.1371/journal.pgen.1000980.s001 (0.18 MB TIF)
Figure S2 Morphological defects and dexamethasone-resistance
in AdKO adrenals of male mice. Representative haematoxylin and
eosin adrenal staining of 10 and 18-month-old males of WT and
AdKO genotype, in basal conditions or after 4 days dexameth-
asone suppression test. Insets, higher magnification illustrating the
increased cell size of expanding eosinophilic cells compared to
normal spongiocytes. The dotted line delineates the cortex-
medulla boundary. Double arrows indicate the cortex. Scale bars,
50 mm.
Found at: doi:10.1371/journal.pgen.1000980.s002 (5.01 MB TIF)
Figure S3 Sensitivity to ACTH of plasma corticosterone levels
in WT and AdKO adrenals. Quantitative analysis of plasma
corticosterone in dexamethasone-treated mice (5-month-old par-
ous females, 5- and 10-month-old males) with or without ACTH
replacement. * p,0.05. NS: statistically non significant.
Found at: doi:10.1371/journal.pgen.1000980.s003 (0.19 MB TIF)
Figure S4 ACTH responsive genes were maintained up-
regulated in AdKO adrenals. A, efficiency of the dexamethasone
suppression test on the expression of genes implicated in
steroidogenesis or detoxification in 5-month-old WT females
(parous) and 10-month-old WT males. B–C, Quantitative
representation of mRNA levels of genes involved in steroidogenesis
or detoxification: Star, Akr1b7, Cyp11a1, Cyp11b1, Cyp11b2. RT-
QPCRs were done with adrenal mRNA from WT and AdKO 10-
month-old parous females and males in basal conditions (B) and
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old males treated with dexamethasone (C). *, P,0.05; ** P,0.01.
Inset, western blot showing basal up-regulation of StAR protein in
AdKO adrenals from 10-month-old females.
Found at: doi:10.1371/journal.pgen.1000980.s004 (0.40 MB TIF)
Figure S5 Maintenance of progenitor cell markers in AdKO
adrenals. Quantitative representation of mRNA levels of the
genes: Shh, Gli-1 and Pod-1. RT-QPCRs were done using adrenal
mRNA from WT and AdKO mice of 10 and 18-month-old
females (parous).
Found at: doi:10.1371/journal.pgen.1000980.s005 (0.11 MB TIF)
Figure S6 INHIBIN-a was overexpressed in the adrenal nodules
of PPNAD patients. INHIBIN-a was immunodetected (in brown)
in adrenal sections of two males (top panels) and two females
(lower panels) PPNAD patients and counter-stained with haema-
toxylin (blue). Scale bars, 50 mm.
Found at: doi:10.1371/journal.pgen.1000980.s006 (4.44 MB TIF)
Figure S7 Existence of a persistent X-like-zone in AdKO female
adrenals. The X-zone 20a-HSD marker (in red) was immunode-
tected, and merged in the right column with the Hoechst nuclei
marker (blue, right column). A–B, Adrenal sections of a 5-month-
old parous WT and AdKO female. The arrows indicate cells
expressing 20a-HSD. C–D, Adrenal sections of a 10-month-old
virgin WT and AdKO female. E–D, Adrenal sections of a 18-
month-old virgin WT and AdKO female. C, cortex; M, Medulla;
X, X-zone; XL, X-like-zone; Scale bars, 50 mm.
Found at: doi:10.1371/journal.pgen.1000980.s007 (3.95 MB TIF)
Figure S8 Evidence for cell proliferation in the X-like-zone of
AdKO mice adrenals. In 10 and 18-month-old parous AdKO
females, the X-zone 20a-HSD marker (in red) and the Ki67
proliferation marker (in green) were co-immunodetected and
merged with the Hoechst nuclei marker (blue). Double-stained
cells are outlined by arrows. XL, X-like-zone; Scale bars, 20 mm.
Found at: doi:10.1371/journal.pgen.1000980.s008 (1.13 MB TIF)
Figure S9 Existence of a persistent, mislocated X-like-zone in
male AdKO adrenals. The X-zone 20a-HSD marker (in red) and
the zona fasciculata Akr1b7 marker (green, right column) were
immunodetected. The two colours are merged in the right column
with the Hoechst nuclei marker (blue). A, Adrenal section of a 18-
month-old WT male. No staining for 20a-HSD was shown. B,
Adrenal section of an 18 month-old AdKO male. Cells doubled-
stained for Akr1b7 and 20a-HSD were detected, as in AdKO
females, indicating the presence of a pathological X-like-zone in
AdKO male adrenals. M, Medulla; F, zona fasciculata;G ,zona
glomerulosa; X, X-zone; XL, X-like-zone; Scale bars, 20 mm.
Found at: doi:10.1371/journal.pgen.1000980.s009 (1.37 MB TIF)
Figure S10 Castration in AdKO males increased the size of
persistent, mislocated X-like-zone and plasma corticosterone
levels. WT and AdKO males were castrated at 3 weeks and kept
for sacrifice at 3 months of age. A, Co-immunostaining for Akr1b7
(green) and 20a-HSD (red) were realised on adrenal sections of
control (left column) and castrated mice of WT and AdKO
genotypes. B, Quantitative analysis of plasma corticosterone in
control and castrated 3-month-old males of WT and AdKO
genotypes. M, Medulla; C, cortex; X, X-zone; XL, X-like-zone;
Scale bars, 20 mm. *, P,0.05.
Found at: doi:10.1371/journal.pgen.1000980.s010 (1.91 MB TIF)
Figure S11 Maintenance of steroidogenesis markers in aging
AdKO adrenals. Quantitative representation of mRNA levels of
the genes: Prkar1a (control), Cyp21, Cyp11b1. RT-QPCRs were
done with adrenal mRNA from WT and AdKO mice in 10 and
18-month-old females (parous). *, P,0.05. NS: statistically non
significant.
Found at: doi:10.1371/journal.pgen.1000980.s011 (0.09 MB TIF)
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